NASDAQ NMS - GLOBAL MARKET · NXTS
-7.22% · -$0.1000 · Vol 43.7K
Live · updated 13:15:48 ET
Nexentis Technologies Inc

Nexentis Technologies Inc

Chemicals
$1.35
Card
Relationship Map

Follow $NXTS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $NXTS by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
NXTS
Nexentis Technologies Inc
Thu Sep 24 · live session · daily score · 1h old
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

48/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Thu Sep 24 · live session · daily score · 1h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NXTS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NXTS catalysts
About Nexentis Technologies Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2009
Employees
9
Country
IL

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.52
Day high
$1.55
Day low
$1.32
Previous close
$1.46
52W high
$13.00
-89.62% from high
52W low
$1.31
0% of range
Market cap
$2.1M
EPS
$-48.8000
Beta
3.16
Shares out
1.5M
Volume
43.7K
1.07× rel vol
Avg volume
40.9K
VWAP
$1.42
Price history computed in-house
1W
-1.46%
1M
-27.03%
3M
-73.00%
SMA 50 $1.80 · below
SMA 200 Not reported · Not reported
52W position 0%

NXTS overview

Veridion Score
48
Registered · 2026-09-23
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around NXTS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading NXTS Form 4 filings
Public disclosures

Congress activity in NXTS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NXTS in the cached public ledger.

Federal contracts

NXTS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NXTS in this window.
Lobbying spend

NXTS lobbying filings, year to date.

Registered lobbying filings matched to Nexentis Technologies Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NXTS in this window.
Loading news for NXTS
Analyst ratings
Sovereign unlock shows live analyst consensus for NXTS.
Options
Sovereign unlock shows live options positioning for NXTS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.